StockTipsArenaBeta

BUY Ajanta Pharma Limited — ICICI Securities

BUYAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)1 Nov 2026via Institutional / Brokerage Research

Entry₹3,477.3Inferred
Target₹4,040
Total upside +16.18%
Stop lossNot given
CMP₹3,307.71d ago
Active-4.88%+22.14%upside left 12 mo left
Follow ICICI Securities for new calls(64% target hit, 1085 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 3 other Long-term calls on AJANTPHARMSee 542 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:25 pm IST
11 supporting2 neutral3 opposing
Supports the BUY call (11)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·6 Nov · yesterday

Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%

NewsCnbc-Tv18·30 Oct · 1w ago

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·10 Aug · 3mo ago

Neutral / worth noting (2)

Ajanta Pharma Q2 Review: Stock Rally Limits Upside Despite Robust Performance, Says Systematix

NewsNdtv-Profit·2 Nov · 5d ago

(opens in new tab)

Pls find enclosed Financial Results for the quarter ended 30.09.2026.

BSE · Board Meeting·30 Oct · 1w ago

(opens in new tab)
Weighs against the BUY call (3)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from ICICI Securities

Every call and its outcome